Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|May 1, 2004

Pharmaceutical Executive

  • Pharmaceutical Executive-05-01-2004

May 2004 Table of Contents

May 2004 Table of Contents

Advertisement
External Link - article-94607.pdf

Articles in this issue

about 22 years ago

Article

The Risk Management Mandate

about 22 years ago

Article

Partners in Learning

about 22 years ago

Article

Early Warnings
Advertisement

Related Content

Advertisement
Ryan Last

Uncertainty Surrounding Pharma Tariff Deadlines

ByMike Hollan,Ryan Last
July 3rd 2026
Ryan Last

Realistic Timelines for Pharma Manufacturing Reshoring

ByMike Hollan,Ryan Last
July 2nd 2026
Pharmaceutical executive daily

Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge

ByNicholas Jacobus
July 1st 2026
stock.adobe.com GLP-1

Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge

ByNicholas Jacobus
July 1st 2026
stock.adobe.com clinical trials

AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS

ByNicholas Jacobus
July 1st 2026
Advertisement
Advertisement

Trending on PharmExec

1

AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS

2

Uncertainty Surrounding Pharma Tariff Deadlines

3

Realistic Timelines for Pharma Manufacturing Reshoring

4

Targeted Onshoring's Impact on Domestic Pharma Manufacturing

5

Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us